Professor Mohammad Najlah has extensive experience as a teacher, researcher, and manager. Mohammad completed a pharmacy degree followed by a postgraduate diploma in industrial pharmacy at Damascus University, Syria, and obtained his PhD from the University of Manchester, UK. His research focusses on the development of drug delivery nano-systems for enhanced bioavailability and optimised therapeutic effects. Working within the interface between industry and academia allows Mohammad to assimilate, then transfer this knowledge between sectors. His research on developing scaling-up technologies for nanomedicines has led to several Knowledge Transfer Partnerships (KTP) and KEEP+ projects, funded by Innovate UK and the European Regional Development Fund, respectively. Mohammad is mainly interested in repurposing safe drugs and natural compounds for anticancer therapy. He has published over 80 peer-reviewed publications in the field of pharmaceutical nanotechnology, filed a patent on novel non-toxic anticancer agents, and supervised PhD students and postdoctoral researchers. At Anglia Ruskin University (ARU), UK, Mohammad established and developed the Pharmaceutical Research Group, based entirely on externally funded projects. He also led the establishment of a ?3.4 million-budgeted multifunctional laboratory, designed to deliver multidisciplinary education and facilitate research in transitional science. He has served in several managerial roles in which he led the establishment of new undergraduate and postgraduate programmes, and has gained extensive experience in study management, supporting research activities and identifying the individual support needs of research and ancillary staff.